Quality of life and impairment in patients with multiple sclerosis
Isaksson et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:64-69.
ABSTRACT
| FULL TEXT
Quality of Life Is Favorable for Most Patients With Multiple Sclerosis: A Population-based Cohort Study
Pittock et al.
Arch Neurol 2004;61:679-686.
ABSTRACT
| FULL TEXT
The use of quality of life measures in multiple sclerosis research
Nortvedt and Riise
Mult Scler 2003;9:63-72.
ABSTRACT
Quality of life in multiple sclerosis: influence of interferon-{beta}1a (Avonex(R)) treatment
Vermersch et al.
Mult Scler 2002;8:377-381.
ABSTRACT
Health-related quality of life
Miller
Mult Scler 2002;8:269-270.
Early Intervention in Planning End-of-Life Care With Ambulatory Geriatric Patients: Results of a Pilot Trial
Schwartz et al.
Arch Intern Med 2002;162:1611-1618.
ABSTRACT
| FULL TEXT
Interferon-{beta}1b in the treatment of secondary progressive MS: Impact on quality of life
Freeman et al.
Neurology 2001;57:1870-1875.
ABSTRACT
| FULL TEXT
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato et al.
Mult Scler 2001;7:340-344.
ABSTRACT
Azathioprine and interferon {beta}-1b treatment in relapsing-remitting multiple sclerosis
MILANESE et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:413-414.
FULL TEXT
Quality of life during the first 6 months of interferon-b treatment in patients with MS
Arnoldus et al.
Mult Scler 2000;6:338-342.
ABSTRACT
Multiple sclerosis, disease modifying treatments and depression: a critical methodological review
Feinstein
Mult Scler 2000;6:343-348.
ABSTRACT
Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a
Nortvedt et al.
Mult Scler 1999;5:317-322.
ABSTRACT
Recent developments in the assessment of quality of life in Multiple Sclerosis (MS)
Fischer et al.
Mult Scler 1999;5:251-259.
ABSTRACT
Recent developments in drug therapy for multiple sclerosis
Smith and Darlington
Mult Scler 1999;5:110-120.
ABSTRACT